Biomanufacturing for clinically advanced cell therapies

Aijaz, A., Li, M., Smith, D., Khong, D., LeBlon, C., Fenton, O. S., Olabisi, R. M., Libutti, S., Tischfield, J., Maus, M. V., Deans, R., Barcia, R. N., Anderson, D. G., Ritz, J., Preti, R., Parekkadan, B. Biomanufacturing for clinically advanced cell therapies.  Nature Biomedical Engineering 2018; 2(6), 362-376. doi:10.1038/s41551-018-0246-6

Read More

Development of Anti-Human Mesothelin-Targeted Chimeric Antigen Receptor Messenger RNA–Transfected Peripheral Blood Lymphocytes for Ovarian Cancer Therapy

Hung, C., Xu, X., Li, L., Ma, Y., Jin, Q., Viley, A., Allen, C., Natarajan, P., Shivakumar, R., Peshwa, M. V. and Emens, L. A. Development of Anti-Human Mesothelin-Targeted Chimeric Antigen Receptor Messenger RNA–Transfected Peripheral Blood Lymphocytes for Ovarian Cancer Therapy. Human Gene Therapy. 2018; 29(5), 614-625. doi:10.1089/hum.2017.080

Read More

Validation of Contrast-Enhanced MRI to Monitor Regenerative Efficacy after Cell Therapy in a Porcine Model of Convalescent Myocardial Infarction

Malliaras, K., Smith, R. R., Kanazawa, H., Yee, K., Seinfeld, J., Tseliou, E., Dawkins, J. F., Kreke, M., Cheng, K., Luthringer, D., Ho, C., Blusztajn, A., Valle, I., Chowdhury, S., Makkar, R. R., Dharmakumar, R., Li, D., Marban, L. and Marban, E.  Validation of Contrast-Enhanced MRI to Monitor Regenerative Efficacy after Cell Therapy in a…

Read More